Literature DB >> 32329323

IncRNA NEAT1 aggravates cerebral ischemia/reperfusion injury by sponging miR-874-3p.

B Liu1, T Xu1, Y Meng2.   

Abstract

Many lncRNAs have been reported to affect cerebral ischemia/reperfusion (I/R) injury. The purpose of this study is to elucidate the role of lncRNA NEAT1 as well as the regulatory mechanism of lncRNA NEAT1/miR-874-3p in cerebral I/R injury. A cellular model of cerebral I/R injury was built. RT-qPCR was used to detect NEAT1 and miR-874-3p expression. Cell viability was detected by MTT assay. The expression of apoptosis-related proteins (Bcl-2 and Bax) was measured by Western blot analysis. The relationship between NEAT1 and miR-874-3p was confirmed by dual luciferase reporter assay. We found that LncRNA NEAT1 was upregulated in the PC12 cells treated by I/R and upregulation of lncRNA NEAT1 can aggravate I/R injury of PC12 cells. Additionally, lncRNA NEAT1 overexpression decreased cell viability and induced apoptosis in PC12 cells treated by I/R. Furthermore, miR-874-3p was confirmed to be a target of lncRNA NEAT1. mR-874-3p and NEAT1 expression are found to be reciprocally inhibited in PC12 cells. In summary, LncRNA NEAT1 aggravates cerebral I/R injury by suppressing miR-874-3p expression. Copyright 2020 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  NEAT1; cerebral ischemia; miR-874-3p ; reperfusion injury

Year:  2020        PMID: 32329323     DOI: 10.23812/20-38A

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  2 in total

1.  Mechanism of protective role of miR-874-3p in intervertebral disc degeneration.

Authors:  Xuefang Yang
Journal:  Ann Transl Med       Date:  2022-02

2.  Comprehensive bioinformatics analyses reveal immune genes responsible for altered immune microenvironment in intervertebral disc degeneration.

Authors:  Bao Hai; Qingpeng Song; Chuanchao Du; Tianli Mao; Fei Jia; Yu Liu; Xiaoyu Pan; Bin Zhu; Xiaoguang Liu
Journal:  Mol Genet Genomics       Date:  2022-06-29       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.